Next-Generation Gel vs. Established HA Technology
Arthrosamid and Durolane both treat knee osteoarthritis with a single injection, but that is where the similarities end. Durolane is an FDA-approved hyaluronic acid that lubricates the joint for 6-12 months. Arthrosamid is a polyacrylamide hydrogel that integrates into the joint capsule lining and may provide relief for 2 or more years. They represent different generations and philosophies of injectable knee treatment.
Side-by-Side Comparison
| Factor | Arthrosamid | Durolane |
|---|---|---|
| Type | Polyacrylamide hydrogel (PAAG) | Hyaluronic acid (NASHA) |
| Injections | 1 (single) | 1 (single) |
| Mechanism | Integrates into synovial lining | Lubricates joint surfaces |
| Duration | 2+ years (some report 3-4) | 6-12 months |
| FDA approved (US) | No (as of 2025) | Yes |
| CE Mark (Europe) | Yes | Yes |
| Self-pay cost | $2,500-$5,000 | $800-$1,300 |
| Medicare | Not covered | Yes |
| Clinical evidence | Growing (European trials) | Established |
Arthrosamid: The Long-Duration Newcomer
Arthrosamid is a non-degradable polyacrylamide hydrogel (2.5% polyacrylamide, 97.5% water). Once injected, it integrates into the synovial membrane (joint lining), where it acts as a cushion and may restore the joint’s ability to produce its own lubrication. Unlike HA, it does not break down over time.
Advantages
Considerations
Durolane: FDA-Approved and Insured
Advantages
Considerations
Cost Over Time: A Closer Look
While Arthrosamid costs much more upfront, the math changes when you consider duration:
| Timeframe | Durolane (repeated) | Arthrosamid (single) |
|---|---|---|
| Year 1 | $800-$1,300 | $2,500-$5,000 |
| Year 2 | $1,600-$2,600 | $0 (still active) |
| Year 3 | $2,400-$3,900 | $0 (may still be active) |
| 3-year total | $2,400-$3,900 | $2,500-$5,000 |
With insurance covering Durolane, the insured cost is much lower. But for self-pay patients, Arthrosamid’s longer duration may make it cost-competitive over 2-3 years.
Making Your Decision
Choose Durolane if:
- You want an FDA-approved treatment
- You have Medicare or private insurance coverage
- You prefer a proven product with established safety data
- You are comfortable with periodic repeat treatments
Consider Arthrosamid if:
- Longer duration matters more than cost
- You can pay out of pocket ($2,500-$5,000)
- You are comfortable with a product not yet FDA-approved in the US
- You have access to a qualified provider offering it
- Repeated HA injections have not provided lasting relief
Frequently Asked Questions
Is Arthrosamid available in the United States?
As of 2025, Arthrosamid is not FDA-approved for use in the US. Some US patients travel to countries where it is available (UK, Europe, Australia). It holds a CE mark in Europe and TGA approval in Australia. US clinical trials are ongoing.
Is polyacrylamide hydrogel safe inside a joint?
Arthrosamid has been used in veterinary medicine for over 15 years (in horses) and in human joints in Europe since 2019. Published safety data are encouraging, but long-term human data (10+ years) are not yet available. The hydrogel is 97.5% water and is biocompatible.
Can I try Durolane first and switch to Arthrosamid later?
Yes. Using Durolane does not prevent future Arthrosamid treatment. Many patients start with HA and later explore longer-lasting alternatives if repeat injections become burdensome.
Will Arthrosamid become FDA-approved?
The manufacturer (Contura) is pursuing US regulatory approval. Clinical trials are underway. If approved, it would likely become insurance-covered, which would change the cost comparison significantly.
Does Arthrosamid affect future knee replacement surgery?
Current evidence suggests that Arthrosamid does not interfere with future surgical options, including knee replacement. This is an important consideration for patients who may eventually need surgery.
The Bottom Line
Durolane is the safe, insured, FDA-approved choice that works for 6-12 months per injection.
Arthrosamid is the emerging long-duration option for patients willing to pay out of pocket for potentially 2+ years of relief.
For most US patients today, Durolane is the practical choice. Arthrosamid is worth watching as clinical data grows and US regulatory approval progresses.
Find Knee Injection Specialists
Connect with providers offering the latest knee OA treatments.
Your information is secure. See our Privacy Policy and Terms of Service.
Thank You!
We've received your request. A provider specialist will contact you within 1-2 business days to help you find the right care.
What happens next?
- 1 We'll verify your insurance coverage
- 2 Match you with quality providers in your area
- 3 Contact you to discuss your options
Questions? Browse our guides:
How to Choose a ProviderKnee Treatment Updates
Stay informed about emerging treatments for knee osteoarthritis.
Join 10,000+ readers. No spam.